Pharmakon Advisorsfirm provided financing to UroGen Pharmacompany in Mar 2024.
WebsitelistingThe website reads: “UroGen Pharma”.
WebsitelistingThe firm's website puts the debt at $250M.
WebsitePharmakon Advisorsfirm lists UroGen Pharmacompany as a past investment.
WebsitePharmakon Advisorsfirm also worked on Kestra Medical Technologiescompany, in Jul 2026.
Websitelisting
At a glance
Who was on each side
Parties
| Party | Role | Source |
|---|---|---|
| Pharmakon Advisors | Buyer | Websitelisting |
Value
| Kind | Amount | Basis | Source |
|---|---|---|---|
| Debt | $250M | senior secured (stated on the firm's site) | Website |
More deals
first 2 of 6
| Date | Deal | Firms | Source |
|---|---|---|---|
| Jul 2026 | Kestra Medical Technologies · Financing | Pharmakon Advisors | Websitelisting |
| Jun 2026 | Mineralys Therapeutics · Financing | Pharmakon Advisors | Websitelisting |
4 more deals
Deals with Pharmakon Advisors, and other deals for UroGen Pharma.
Sign up free to see the first 5, or become a member to see all 6.
On file
- Date as stated
- March 2024Websitelisting